非酒精性脂肪性肝炎诊断与治疗：患者与初级保健医生视角的横断面调查

数据集获取（Figshare）

• 源站标题：Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey
• DOI：10.6084/m9.figshare.22812022.v1
• 发布日期：2023-05-12
• 文件数：2 个
• 文件总体积：767.96 KB
• 源站页面：https://tandf.figshare.com/articles/dataset/Nonalcoholic_steatohepatitis_diagnosis_and_treatment_from_the_perspective_of_patients_and_primary_care_physicians_a_cross-sectional_survey/22812022

命令行下载

curl -L -o "iann_a_2211349_sm1922.pdf" "https://ndownloader.figshare.com/files/40553683"
curl -L -o "iann_a_2211349_sm1892.pdf" "https://ndownloader.figshare.com/files/40553686"

文件清单

• iann_a_2211349_sm1922.pdf（408.60 KB）
• iann_a_2211349_sm1892.pdf（359.36 KB）

文件总体积 767.96 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

The global prevalence of nonalcoholic steatohepatitis (NASH) is rising. Despite this, NASH is underdiagnosed and does not yet have approved pharmacological treatments. We sought to understand the path to diagnosis, patient interactions with healthcare professionals, treatment regimens, and disease management for patients with NASH.
Cross-sectional online surveys of patients with a self-reported diagnosis of NASH and healthcare professionals treating patients with NASH were conducted from 10th November 2020, to 1st January 2021. This manuscript focuses on responses from 152 patients with NASH and 101 primary care physicians (PCPs).
Patients (n = 152, mean age = 40, SD = 11) and healthcare professionals (n = 226) were located throughout the US. In the most common patient journey, 72% of patients had initial discussions about symptoms with a PCP but only 30% report receiving their NASH diagnosis from a PCP. Almost half of PCPs (47%) were not aware of any clinical practice guidelines for diagnosis and management of NASH. For ongoing management of NASH, PCPs most frequently prescribed lifestyle changes such as exercise (89%), lifestyle changes focused on diet (79%), and/or metformin (57%). Other healthcare professionals rarely referred patients to PCPs for treatment, but when they did, the primary reasons were patients struggling with lifestyle modifications (58%), needing to lose weight (46%), and needing treatment of comorbidities (42%).
PCPs may benefit from greater awareness of NASH and guidelines for its diagnosis and treatment. Given the absence of pharmacological treatments approved for NASH, PCPs can offer support in obesity management, comorbidity management, and risk stratification for liver disease progression.
Nonalcoholic steatohepatitis (NASH) is a form of nonalcoholic fatty liver disease (NAFLD) with a higher risk of more severe liver disease. Patients with NASH have too much fat deposited in their liver with associated liver inflammation, scarring, and, in some patients, liver failure. Patients with NASH may not experience symptoms until their disease reaches a dangerous point. We wanted to understand how patients with NASH are diagnosed, how they

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.22812022.v1（source: https://tandf.figshare.com/articles/dataset/Nonalcoholic_steatohepatitis_diagnosis_and_treatment_from_the_perspective_of_patients_and_primary_care_physicians_a_cross-sectional_survey/22812022）。